This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked NLGN1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NLGN1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~96.4 kDa | |
| Observed band | ~116 kDa | |
| Gel | 8% (catalog A04948-1) | |
| Positive control | Cerebral cortex (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Glycosylated + Cleaved | |
| Caveat | Glycosylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The A04948-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human Hela, human U251, rat C6 (catalog A04948-1) |
| Gel % | 8% (catalog A04948-1) |
| Load | 30 ug; reducing conditions (catalog A04948-1) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A04948-1) |
| Membrane | nitrocellulose membrane (catalog A04948-1) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A04948-1) |
| Primary antibody | A04948-1 · 0.5 μg/mL (catalog A04948-1) |
| Primary incubation | overnight at 4°C (catalog A04948-1) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A04948-1) |
| Secondary incubation | 1.5 hour at RT (catalog A04948-1) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A04948-1) |
| Detection | ECL (catalog A04948-1) |
NLGN1 is predicted at 96.4 kDa and observed near 116 kDa in reducing whole-cell lysates; the cause of the difference is not established.
| Band at ~116 kDa | Empirical NLGN1 band in reducing whole-cell lysates; its difference from the predicted mass is unexplained |
| Band near 96.4 kDa | Near the predicted mass of the full-length precursor; confirm its identity |
| Band below the precursor size | Signal-peptide cleavage could contribute to a smaller mature protein; identity requires confirmation |
| Multiple bands | Isoforms 1 and 2 or different glycosylation states are possible; distinct migration is unestablished |
| Broad smear | Variable N- or O-linked glycosylation is possible; the listed sites alone do not establish a smear |
| Predicted full-length mass | 96.4 kDa is the sequence-based precursor reference, while the empirical band is ~116 kDa |
| N-linked sites at Asn109, Asn323, Asn363, and Asn567 | Glycosylation could alter apparent migration; its contribution to the ~116 kDa band is unproven |
| O-linked sites at Ser703 and Ser706 | Glycosylation could alter apparent migration; site annotations do not establish a visible shift |
| Signal peptide at residues 1–45 | Cleavage can make mature protein smaller than the full-length precursor; no mature mass is supplied |
| Isoforms 1 and 2 | Alternative splicing may change size, but their masses and migration difference are unknown |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Membrane-associated NLGN1 may be poorly recovered | Check membrane extraction and test a membrane-enriched fraction |
| Band higher than expected | The ~116 kDa empirical band exceeds the 96.4 kDa predicted mass; the cause is unestablished | Compare with the ~116 kDa reference and confirm identity with an independent antibody or NLGN1-depleted sample |
| Band lower than expected | Signal-peptide cleavage or an alternative isoform is possible | Check antibody epitope coverage and confirm identity with an independent antibody or NLGN1-depleted sample |
| Broad smear instead of sharp band | Variable glycosylation is possible but not demonstrated | Compare matched samples with and without appropriate glycosidase treatment |
| Multiple bands | Isoforms or different glycosylation states are possible; distinct bands are not established | Use an independent antibody or NLGN1-depleted sample to identify specific bands |
| Weak or no signal | Membrane protein recovery or expression may be low in the sampled cells | Check lysate loading and extraction, then test an NLGN1-positive sample |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Cerebral cortex | neuronal cells | High | Protein (IHC) | HPA → |
| Hippocampus | neuronal cells | High | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Medium | Protein (IHC) | HPA → |
| Caudate | neuronal cells | Medium | Protein (IHC) | HPA → |
| Epididymis | glandular cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Colon | glandular cells | Not detected | Protein (IHC) | HPA → |
| Endometrium | cells in endometrial stroma | Not detected | Protein (IHC) | HPA → |
| Esophagus | squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for NLGN1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-NLGN1 antibody for Western blot, A04948-1, with reported human and rat reactivity. Its WB image uses HeLa, U251, and rat C6 whole-cell lysates. The caption reports a band near 116 kDa, versus an expected 96 kDa; no independent validation is supplied.
Which to pick: A04948-1 is the only listed option and has a WB image from human HeLa and U251 and rat C6 lysates. Match your sample to those tested contexts and assess the reported 116 kDa band against the expected 96 kDa size.